Halozyme Therapeutics shares owned by Portolan Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Portolan Capital Management
from 13F filings
Historical chart of Portolan Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Portolan Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Portolan Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $10M | 128k | 78.27 |
| 2021-03-31 | $6.1M | 146k | 41.69 |
| 2020-12-31 | $8.9M | 209k | 42.71 |
| 2020-09-30 | $11M | 406k | 26.28 |
| 2020-06-30 | $14M | 533k | 26.81 |
| 2020-03-31 | $5.6M | 309k | 17.99 |
More positions owned by Portolan Capital Management
View all positions for Portolan Capital Management